2,143
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Immunotherapeutic effect of BCG-polysaccharide nucleic acid powder on Mycobacterium tuberculosis-infected mice using microneedle patches

, , , , , , & show all
Pages 1648-1653 | Received 28 Aug 2017, Accepted 10 Oct 2017, Published online: 25 Oct 2017

References

  • Chen F, Yan Q, Yu Y, Wu MX. (2017). BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination. J Control Release 255:36–44.
  • Chen X, Kositratna G, Zhou C, et al. (2014). Micro-fractional epidermal powder delivery for improved skin vaccination. J Control Release 192:310–16.
  • Donnelly RF, Singh TRR, Woolfson AD. (2010). Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv 17:187–207.
  • Flynn JL, Chan J, Triebold KJ, et al. (1993). An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178:2249–54.
  • Fraser J, Laurent T, Laurent U. (1997). Hyaluronan: its nature, distribution, functions and turnover. J Internal Med 242:27–33.
  • Gill HS, Denson DD, Burris BA, Prausnitz MR. (2008). Effect of microneedle design on pain in human volunteers. Clin J Pain 24:585.
  • Günther G. (2014). Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges. Clin Med 14:279–85.
  • Hiraishi Y, Nandakumar S, Choi SO, et al. (2011). Bacillus Calmette-Guérin vaccination using a microneedle patch. Vaccine 29:2626–36.
  • Kim YC, Park JH, Prausnitz MR. (2012). Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 64:1547–68.
  • Kumar MNK, Zhou C, Wu MX. (2016). Laser-facilitated epicutaneous immunotherapy to IgE-mediated allergy. J Control Release 235:82–90.
  • Kupper TS, Fuhlbrigge RC. (2004). Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 4:211.
  • Liu W, Wang H, Yu J, et al. (2016). Structure, chain conformation, and immunomodulatory activity of the polysaccharide purified from Bacillus Calmette Guerin formulation. Carbohydr Polym 150:149–58.
  • Matteelli A, Roggi A, Carvalho AC. (2014). Extensively drug-resistant tuberculosis: epidemiology and management. Clin Epidemiol 6:111.
  • Mitragotri S. (2005). Immunization without needles. Nat Rev Immunol 5:905.
  • Munsiff SS, Nivin B, Sacajiu G, et al. (2003). Persistence of a highly resistant strain of tuberculosis in New York City during 1990–1999. J Infect Dis 188:356–63.
  • Parida S, Axelsson, Robertson R, et al. (2015). Totally drug‐resistant tuberculosis and adjunct therapies. J Intern Med 277:388–405.
  • Rodriguez L, Tirado Y, Reyes F, et al. (2011). Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice. Vaccine 29:6236–41.
  • Saunders B, Briscoe H, Britton W. (2004). T cell‐derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection. Clin Exp Immunol 137:279–87.
  • Sullivan SP, Murthy N, Prausnitz MR. (2008). Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Mater 20:933–8.
  • Sun J, Hou J, Li D, et al. (2013). Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant. Vaccine 31:472–9.
  • Tirado Y, Puig A, Alvarez N, et al. (2015). Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis. Human Vaccines Immunother 11:657–61.
  • Wang LH, Ye Y, Zhang YQ, Xiao T. (2014). Curative effect of BCG-polysaccharide nuceic acid on atopic dermatitis in mice. Asian Pacific J Tropical Med 7:913–17.
  • Wei D, Chen T, Yan M, et al. (2015). Synthesis, characterization, antioxidant activity and neuroprotective effects of selenium polysaccharide from Radix hedysari. Carbohydr Polym 125:161–8.
  • World Health Organization (WHO). 2016. Global tuberculosis report 2016. Geneva: WHO.
  • Xiong C, Li Q, Lin M, et al. (2009). The efficacy of topical intralesional BCG‐PSN injection in the treatment of erosive oral lichen planus: a randomized controlled trial. J Oral Pathol Med 38:551–8.
  • Xu X, Gu Z, Liu S, et al. (2015). Purification and characterization of a glucan from Bacillus Calmette Guerin and the antitumor activity of its sulfated derivative. Carbohydr Polym 128:138–46.